Management of cardiovascular complications in Klinefelter syndrome patients

References

• Calogero AE, Giagulli VA, Mongioì LM, et al. Klinefelter syndrome: cardiovascular abnormalities and metabolic disorders. J Endocrinol Invest. 2017;40(7):705–712.
   Web of Science ®Google Scholar
• Bojesen A, Juul S, Gravholt CH. Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry study. J Clin Endocrinol Metab. 2003;88(2):622–626.
   PubMed Web of Science ®Google Scholar
• Forti G, Corona G, Vignozzi L, et al. Klinefelter’s syndrome: a clinical and therapeutical update. Sex Dev Genet Mol Biol Evol Endocrinol Embryol Pathol Determ Differ. 2010;4(4–5):249–258.
   Google Scholar
• Bojesen A, Juul S, Birkebaek N, et al. Morbidity in Klinefelter’s syndrome: a Danish register study based on hospital discharge diagnoses. J Clin Endocrinol Metab. 2006;91(4):1254–1260.
   PubMed Web of Science ®Google Scholar
• Salzano A, Arcopinto M, Marra AM, et al. Klinefelter syndrome, cardiovascular system, and thromboembolic disease: review of literature and clinical perspectives. Eur J Endocrinol. 2016;175(1):R27–R40.
   PubMed Web of Science ®Google Scholar
• Bojesen A, Gravholt CH. Morbidity and mortality in Klinefelter syndrome (47,XXY). Acta Paediatr. 2011;100:807–813.
   PubMed Web of Science ®Google Scholar
• Bojesen A, Juul S, Birkebaek N, et al. Increased mortality in Klinefelter syndrome. J Clin Endocrinol Metab. 2004;89:3830–3834.
   PubMed Web of Science ®Google Scholar
• Swerdlow AJ, Higgins CD, Schoemaker MJ, et al. Mortality in patients with Klinefelter syndrome in Britain: a cohort study. J Clin Endocrinol Metab. 2005;90:6516–6522.
   PubMed Web of Science ®Google Scholar
• Price WH, Clayton JF, Collyer S, et al. Mortality ratios and life expectancy in X chromatin positive males. J Epidemiol Community Health. 1985;39:33–38.
   PubMed Web of Science ®Google Scholar
• Bojesen A, Stochholm K, Juul S, et al. Socio- economic trajectories affect mortality in Klinefelter syndrome. J Clin Endocrinol Metab. 2011;96:2098–2104.
   PubMed Web of Science ®Google Scholar
• Bardsley MZ, Falkner B, Kowal K, et al. Insulin resistance and metabolic syndrome in prepubertal boys with Klinefelter syndrome. Acta Paediatr. 2011;100:866–870.
   PubMed Web of Science ®Google Scholar
• Bw E, Boddy K, Price WH. Total body potassium content in males with X and Y chromosome abnormalities. Clin Endocrinol. 1976;5:43–51.
   PubMed Web of Science ®Google Scholar
• Aksglaede L, Molgaard C, Skakkebaek NE, et al. Normal bone mineral content but unfavourable muscle/fat ratio in Klinefelter syndrome. Arch Dis Child. 2008;93:30–34.
   PubMed Web of Science ®Google Scholar
• Bojesen A, Kristensen K, Birkebaek NH, et al. The metabolic syndrome is frequent in Klinefelter’s syndrome and is associated with abdominal obesity and hypogonadism. Diabetes Care. 2006;297:1591–1598.
   Google Scholar
• Nielsen J, Johansen K, Yde H. Frequency of diabetes mellitus in patients with Klinefelter’s syndrome of different chromosome constitutions and the XYY syndrome. Plasma insulin and growth hormone level after a glucose load. J Clin Endocrinol Metab. 1969;29:1062–1073.
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Yamaguchi K, Kondo Y, et al. Metabolic syndrome in men with Klinefelter’s syndrome. Urology. 2008;71:1109–1113
   PubMed Web of Science ®Google Scholar
• Pasquali D, Arcopinto M, Renzullo A, et al. Cardiovascular abnormalities in Klinefelter syndrome. Int J Cardiol. 2013;168:754–759.
   PubMed Web of Science ®Google Scholar
• Andersen NH, Bojesen A, Kristensen K, et al. Left ventricular dysfunction in Klinefelter syndrome is associated to insulin resistance, abdominal adiposity and hypogonadism. Clin Endocrinol. 2008;69:785–791.
   PubMed Web of Science ®Google Scholar
• Di Minno MN, Esposito D, Di Minno A, et al. Increased platelet reactivity in Klinefelter men: something new to consider. Andrology. 2015;3(5):876–881.
   PubMed Web of Science ®Google Scholar
• Tsai EC, Boyko EJ, Leonetti DL, et al. Low serum testosterone level as a predictor of increased visceral fat in Japanese-American men. Int J Obes Relat Metab Disord. 2000;24:485–491.
   PubMed Web of Science ®Google Scholar
• Corona G, Mannucci E, Forti G, et al. Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases. Int J Androl. 2009;32:587–598.
   PubMedGoogle Scholar
• Ding EL, Song Y, Malik VS, et al. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2006;295:1288–1299.
   PubMed Web of Science ®Google Scholar
• Corona G, Rastrelli G, Monami M, et al. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol. 2013;168:829–843.
   PubMed Web of Science ®Google Scholar
• Yialamas MA, Dwyer AA, Hanley E, et al. Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2007;92:4254–4259.
   PubMed Web of Science ®Google Scholar
• Marin P, Holmang S, Gustafsson C, et al. Androgen treatment of abdominally obese men. Obes Res. 1993;1:245–251.
   PubMedGoogle Scholar
• Morishima A, Grumbach MM, Simpson ER, et al. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab. 1995;80:3689–3698.
   PubMed Web of Science ®Google Scholar
• Herrmann BL, Saller B, Janssen OE, et al. Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP 19 gene. J Clin Endocrinol Metab. 2002;87:5476–5484.
   PubMed Web of Science ®Google Scholar
• Maffei L, Murata Y, Rochira V, et al. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metab. 2004;89:61–70.
   PubMed Web of Science ®Google Scholar
• Jones ME, Thorburn AW, Britt KL, et al. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA. 2000;97:12735–12740.
   PubMed Web of Science ®Google Scholar
• Takeda K, Toda K, Saibara T, et al. Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J Endocrinol. 2003;176:237–246.
   PubMed Web of Science ®Google Scholar
• Smith EP, Boyd J, Frank GR. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 1994;331:1056–1061.
   PubMed Web of Science ®Google Scholar
• Heine PA, Taylor JA, Iwamoto GA, et al. Increased adipose tissue in male and female estrogen receptor-α knockout mice. Proc Natl Acad Sci USA. 2000;97:12729–12734.
   PubMed Web of Science ®Google Scholar
• Lapauw B, Ouwens M, ‘t Hart LM, et al. Sex steroids affect triglyceride handling, glucose-dependent insulinotropic polypeptide, and insulin sensitivity: a 1-week randomized clinical trial in healthy young men. Diabetes Care. 2010;33(8):1831–1833.
   PubMed Web of Science ®Google Scholar
• Corona G, Giagulli VA, Maseroli E, et al. Therapy of endocrine: testosterone supplementation and body composition: results from a meta-analysis study. Eur J Endocrinol. 2016;174:R99–R116.
   PubMed Web of Science ®Google Scholar
• Corona G, Giagulli VA, Maseroli E, et al. Testosterone supplementation and body composition: results from a meta- analysis of observational studies. J Endocrinol Invest. 2016;9:967–981.
   Google Scholar
• Giagulli VA, Carbone MD, Ramunni MI, et al. Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypog- onadism. Andrology. 2015;3:1094–1103.
   PubMed Web of Science ®Google Scholar
• Zitzmann M, Depenbusch M, Gromoll J, et al. X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients. J Clin Endocrinol Metab. 2004;89:6208–6217.
   PubMed Web of Science ®Google Scholar
• Zitzmann M, Bongers R, Werler S, et al. Gene expression patterns in relation to the clinical phenotype in Klinefel- ter syndrome. J Clin Endocrinol Metab. 2015;100:E518–E523.
   PubMed Web of Science ®Google Scholar
• Rotondi M, Coperchini F, Renzullo A, et al. High circulating levels of CCL2 in patients with Klinefelter’s syndrome. Clin Endocrinol. 2014;80:465–467.
   PubMed Web of Science ®Google Scholar
• Schmidt-Lucke C, Rossig L, Fichtlscherer S, et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation. 2005;111:2981–2987.
   PubMed Web of Science ®Google Scholar
• Mambro D, Ferlin A, De Toni L, et al. Endothelial progenitor cells as a new cardiovascular risk factor in Klinefelter’s syndrome. Mol Hum Reprod. 2010;16:411–417.
   PubMed Web of Science ®Google Scholar
• Foresta C, Caretta N, Lana A, et al. Reduced number of circulating endothelial progenitor cells in hypogonadal men. J Clin Endocrinol Metab. 2006;91:4599–4602.
   PubMed Web of Science ®Google Scholar
• Foresta C, Ferlin A, De Toni L, et al. Circulating endothelial progenitor cells and endothelial function after chronic Tadalafil treatment in subjects with erectile dysfunction. Int J Impot Res. 2006;18:484–488.
   PubMed Web of Science ®Google Scholar
• Ru BZ, Gao XC, Yue WW, et al. Testosterone level not significantly correlates to endothelial progenitor cells in Klinefelter’s syndrome patients. Zhonghua Nan Ke Xue. 2012;18:67–69.
   PubMedGoogle Scholar
• Condorelli RA, Calogero AE, La Vignera S. Different profile of endothelial cell apoptosis in patients with Klinefelter’s syndrome. J Endocrinol Invest. 2013;36:84–91.
   PubMed Web of Science ®Google Scholar
• Jorgensen IN, Skakkebaek A, Andersen NH, et al. Short QTc interval in males with klinefelter syndrome-influence of CAG repeat length, body composition, and testosterone replacement therapy. PacingClinElectrophysiol. 2015;38:472–482.
   PubMed Web of Science ®Google Scholar
• Zitzmann M, Bongers R, Werler S, et al. Gene expression patterns in relation to the clinical phenotype in Klinefelter syndrome. J Clin Endocrinol Metab. 2015;100:E518–E523.
   PubMed Web of Science ®Google Scholar
• Karagoz A, Dikbas O, Teker E, et al. Sinus node dysfunction requiring permanent pacemaker implantation in a young adult with Klinefelter syndrome. Am J Case Rep. 2015;16:136–139.
   PubMed Web of Science ®Google Scholar
• Fricke GR, Mattern HJ, Schweikert HU, et al. Klinefelter’s syndrome and mitral valve prolapse. An echocardiographic study in twenty-two patients. Biomed Pharmacother. 1984;38:88–97.
   PubMed Web of Science ®Google Scholar
• Fricke GR, Mattern HJ, Schweikert HU. Mitral valve prolapse in Klinefeltersyndrome. Lancet. 1981;2:1414.
   PubMed Web of Science ®Google Scholar
• Fang ZY, Leano R, Marwick TH. Relationship between longitudinal and radial contractility in subclinical diabetic heart disease. Clin Sci (Lond). 2004;106:53–60.
   PubMed Web of Science ®Google Scholar
• Di Bello V, Santini F, Di Cori A, et al. Relationship between preclinical abnormalities of global and regional left ventricular function and insulin resistance in severe obesity: a Color Doppler imaging study. Int J Obes (Lond). 2006;30:948–956.
   PubMed Web of Science ®Google Scholar
• Cittadini A, Marra AM, Arcopinto M, et al. Growth hormone replacement delays the progression of chronic heart failure combined with growth hormone deficiency: an extension of a randomized controlled single-blind study. JACC Heart Fail. 2013;1:325–330.
   PubMed Web of Science ®Google Scholar
• Brubaker PH, Kitzman DW. Chronotropic incompetence: causes, consequences, and management. Circulation. 2011;123:1010–1020.
   PubMed Web of Science ®Google Scholar
• Lauer MS, Francis GS, Okin PM, et al. Impaired chronotropic response to exercise stress testing as a predictor of mortality. JAMA. 1999;281:524–529.
   PubMed Web of Science ®Google Scholar
• Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) study, 1987–1993. Am J Epidemiol. 1997;146:483–494.
   PubMed Web of Science ®Google Scholar
• Lorenz MW, Markus HS, Bots ML, et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115:459–467.
   PubMed Web of Science ®Google Scholar
• Foresta C, Caretta N, Palego P, et al. Reduced artery diameters in Klinefelter syndrome. Int J Androl. 2012;35:720–725.
   PubMedGoogle Scholar
• Stein JH, Korcarz CE, Hurst RT, et al. Post WS & American Society of Echocardiography carotid intima-media thickness task force. Use
of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from
the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008;21:93–111.
   PubMed Web of Science ®Google Scholar
• Tuttelmann F, Damm OS, Luetjens CM, et al. Intratesticular testosterone is increased in men with Klinefelter syndrome and may not be released into the bloodstream owing to altered testicular vascularization – a preliminary report. Andrology. 2014;2:275–281.
   PubMed Web of Science ®Google Scholar
• Radicioni AF, De Marco E, Gianfrilli D, et al. Strategies and advantages of early diagnosis in Klinefelter’s syndrome. Mol Hum Reprod. 2010;16:434–440.
   PubMed Web of Science ®Google Scholar
• Panimolle F, Tiberti C, Granato S, et al. Screening of endocrine organ-specific humoral autoimmunity in 47,XXY Klinefelter’s syndrome revealsa significant increase in diabetes-specific immunoreactivity in comparison with healthy control men. Endocrine. 2015;49:606–610.
   PubMedGoogle Scholar
• Emerit I, de Grouchy J, Vernant P, et al. Chromosomal abnormalities and congenital heart disease. Circulation. 1967;36:886–905.
   PubMed Web of Science ®Google Scholar
• Blue GM, Kirk EP, Sholler GF, et al. Congenital heart disease: current knowledge about causes and inheritance. Med J Aust. 2012;197:155–159.
   PubMed Web of Science ®Google Scholar
• Swaminathan S, Gorla SR, Barbouth DS. Klinefelter syndrome in association with tetralogy of Fallot and congenital diaphragmatic hernia. J Pediatr Genet. 2017;6(2):115–117.
   PubMed Web of Science ®Google Scholar
• Rosenthal A. Cardiovascularmalformations in Klinefelter’ssyndrome: report of threecases. J Pediatr. 1972;80(3):471–473.
   PubMedGoogle Scholar
• Adatia I, Coe JY, Harder J. Transposition of the great arteries in a neonate with Klinefelter’s syndrome. Pediatr Cardiol. 1987;8:285–286.
   PubMed Web of Science ®Google Scholar
• Agarwal S, Dekam MJ. Multiple cardiac anomalies in an elderly man with Klinefelter’s syndrome. Singapore Med J. 2011;52:15–17.
   PubMed Web of Science ®Google Scholar
• Said SA, Bucx JJ. van de Weel FA. Coronary-cameral fistula in association with Klinefelter syndrome: exercise-induced ventricular tachycardia late after surgical ligation. Int J Cardiol. 1992;36:111–114.
   PubMed Web of Science ®Google Scholar
• Brambilla M, Parolari A, Camera M, et al. Effect of two doses of aspirin on thromboxane biosynthesis and platelet function in patients undergoing coronary surgery.Thromb. Haemost. 2010;103(3):516–524.
   Google Scholar
• Di Minno MN, Iervolino S, Peluso R, et al. Platelet reactivity and disease activity in subjects with psoriatic arthritis. J Rheumatol. 2012b;39:334–336.
   PubMed Web of Science ®Google Scholar
• Lupoli R, Di Minno MN, Tortora A, et al. Primary and secondary haemostasis in patients with subclinical hypothyroidism: effect of Levothyroxine treatment. J Clin Endocrinol Metab. 2015;100:2659–2665.
   PubMed Web of Science ®Google Scholar
• Di Minno MN, Pezzullo S, Palmieri V, et al. Genotype‐independent in vivo oxidative stress following a methionine loading test: maximal platelet activation in subjects with early‐onset thrombosis. Thromb Res. 2011;128:43–48.
   Web of Science ®Google Scholar
• Di Minno MN, Cavalca V, D’angelo A, et al. Urinary excretion of iPF(2α)‐III predicts the risk of future thrombotic events. A 10‐year follow‐up. Thromb Res. 2012;129:208–211.
   PubMed Web of Science ®Google Scholar
• Michelson A. Platelets. 3rd ed. Boston, MA, USA; London: Elsevier, Harvard University Medical School; 2013.
   Google Scholar
• Igawa K, Nishioka K. Leg ulcer in Klinefelter’s syndrome. J Eur Acad Dermatol Venereol. 2003;17(1):62–64.
   PubMed Web of Science ®Google Scholar
• Price WH, Clayton JF, Wilson J, et al. Causes of death in X chromatin positive males (Klinefelter’s syndrome). J Epidemiol Community Health. 1985;39(4):330–336.
   PubMed Web of Science ®Google Scholar
• Kominato Y, Fujikura T, Matsui K, et al. Acute cerebellar hemorrhage in a patient with Klinefelter syndrome: XXY karyotype obtained postmortem from cells from pericardial fluid. J Forensic Sci. 2000;45(5):1148–1150.
   PubMed Web of Science ®Google Scholar
• Aksglaede L, Link K, Giwercman A, et al. 47,XXY Klinefelter syndrome: clinical characteristics and age-specific recommendations for medical management. Am J Med Gen Part C. 2013;163C:55–63.
   PubMed Web of Science ®Google Scholar
• Lanfranco F, Kamischke A, Zitzmann M, et al. Klinefelter’ssyndrome. Lancet. 2004;364:273–283.
   PubMed Web of Science ®Google Scholar
• Bojesen A, Gravholt CH. Klinefelter syndrome in clinical practice. Nat Clin Pract Urol. 2007;4:192–204.
   PubMedGoogle Scholar
• Radicioni AF, Ferlin A, Balercia G, et al. Consensus statement on diagnosis and clinical management of Klinefelter syndrome. J Endocrinol Invest. 2010;33:839–850.
   PubMed Web of Science ®Google Scholar
• Groth KA, Skakkebaek A, Host C, et al. Clinical review: Klinefelter syndrome – a clinical update. J Clin Endocrinol Metab. 2013;98:20–30.
   PubMed Web of Science ®Google Scholar
• Gies I, Unuane D, Velkeniers B, et al. Management of Klinefelter syndrome during transition. Eur J Endocrinol. 2014;171:R67–77.
   PubMed Web of Science ®Google Scholar
• Nieschlag E, Werler S, Wistuba J, et al. New approaches to the Klinefelter syndrome. Ann Endocrinol (Paris). 2014;75:88–97.
   PubMed Web of Science ®Google Scholar
• Perk J, De Backer G, Gohlke H, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the EUROPEAN SOCIETY of Cardiology and Other Societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2012;33:1635–1701.
   PubMed Web of Science ®Google Scholar
• Zannad F, Dallongeville J, Macfadyen RJ, et al. Prevention of cardiovascular disease guided by total risk estimations – challenges and opportunities for practical implementation: highlights of a Cardio Vascular Clinical Trialists (CVCT) workshop of the ESC working group on cardio vascular pharmacology and drug therapy. Eur J Prev Cardiol. 2012;19:241–249.
   PubMed Web of Science ®Google Scholar